Ochre News
NEWS COVERAGE
Ochre Bio announces partnership with Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced liver disease
Ochre Bio with CEO/Co-founder Jack O’Meara and liver expert Dr Scott Friedman, Mount Sinai
Revolutionising Liver Transplants: Can Phenotyping Drive Biotech Transformation in Healthcare?
The intersection between healthcare, technology, strategy and impact – Interview with Ochre Bio’s CEO and co-founder Jack O’Meara
‘I wanted to do something in health but I didn’t want to be a doctor’: Ochre Bio founder Jack O’Meara
A liver disease upstart with some global connections and a new R&D strategy reaps a $30M launch round
Chirps, chats and Clubhouses: First-time biotech founders turn to social media for advice, investors and recruitment
Lyfebulb and CSL Behring Announce the Finalists for the 2021 Transplant Innovation Challenge
‘Day job and a gay job’: LGBTQ+ leaders in biopharma want those who look, talk and love like them to be seen and counted
